Literature DB >> 48365

Hepatic artery ligation and cytotoxic infusion in treatment of liver neoplasms.

W L Zike, S Safaie-Shirazi, H P Gulesserian.   

Abstract

Since 1970, 38 patients with multiple primary or secondary liver neoplasms have been treated by hepatic artery ligation and distal cytotoxic infusion with fluorouracil. There have been two postoperative deaths. Although liver enzymes (alkaline phosphatase, serum glutamic oxaloacetic transaminase, and lactic dehydrogenase) rise markedly during the first three days, they usually return to preoperative levels within eight days. The median survival time of all patients, including the two postoperative deaths, was 13.3 months. The longest patient survival was 44 months. In the eight patients still living, the median survival time is 17 months, ranging from 11 to 27 months. Substantial palliation can be achieved by hepatic artery ligation and infusion with minimal morbidity and mortality.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 48365     DOI: 10.1001/archsurg.1975.01360110187031

Source DB:  PubMed          Journal:  Arch Surg        ISSN: 0004-0010


  3 in total

1.  The prevention of arterial collaterals after repeated temporary blockade of the hepatic artery in pigs.

Authors:  B G Persson; B Jeppsson; L Andersson; S E Strand; L Ekelund; S Bengmark
Journal:  World J Surg       Date:  1987-10       Impact factor: 3.352

2.  Transient hepatic dearterialization followed by regional intra-arterial 5-fluorouracil infusion as treatment for liver tumors.

Authors:  E P Dahl; P E Frelund; U Tylén; S Bengmark
Journal:  Ann Surg       Date:  1981-01       Impact factor: 12.969

3.  Experimental studies on the treatment of nonresectable liver cancer.

Authors:  H Yukaya; N Nagasue; K Inokuchi
Journal:  Jpn J Surg       Date:  1981-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.